The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Adalimumab (Brand name: Humira)
- Manufactured by
AbbVie Inc.
FDA-approved indication: Treatment of Juvenile Idiopathic Arthritis.
Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate.
National Library of Medicine Drug Information PortalMedline Plus Health Information
Infliximab (Brand name: Remicade)
- Manufactured by
Centocor, Inc.
FDA-approved indication: For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy.
National Library of Medicine Drug Information PortalMedline Plus Health Information